STE insider: 4,110-share sale, 2,226-share option grant and RSUs disclosed

Rhea-AI Filing Summary

Mohsen Sohi, a director of STERIS plc (STE), reported multiple equity transactions in August 2025. On 08/11/2025 the filings show a sale of 4,110 ordinary shares at a weighted average price of $241.96 per share and a related entry reflecting 4,110 ordinary shares associated with a $64.05 price. After the reported transactions, the form lists 22,361 ordinary shares beneficially owned directly by the reporting person.

Separately, on 08/08/2025 the reporting person received equity awards: a nonqualified director stock option to purchase 2,226 ordinary shares at an exercise price of $242.85 (described as fully vested and exercisable immediately), plus career restricted stock units of 772 and 506 ordinary shares. The filing notes the 506 RSUs were issued in lieu of $123,000 in fees and that career RSUs generally settle in ordinary shares six months after cessation of board service. An additional option to purchase 4,110 ordinary shares at $64.05 (fully vested) is also disclosed.

Positive

• Receipt of a fully vested nonqualified option to purchase 2,226 ordinary shares at $242.85, exercisable immediately as stated.
• Career Restricted Stock Units awarded totaling 1,278 ordinary shares (772 and 506), with explicit settlement terms (six months after cessation of board service).
• 506 RSUs issued in lieu of $123,000 in fees, indicating compensation was converted to equity rather than cash.

Negative

• Sale of 4,110 ordinary shares on 08/11/2025 at a weighted average price of $241.96, which reduced direct beneficial ownership reported to 22,361 shares.
• Multiple option and RSU awards create potential future share issuance and dilution (options for 2,226 and 4,110 shares plus 1,278 RSUs disclosed).

Insights

Financial Analyst

TL;DR: Director sold 4,110 shares while receiving vested options and RSUs; overall impact appears routine and neutral.

The filing documents an insider sale of 4,110 ordinary shares at a weighted average of $241.96, together with contemporaneous recognition of option and RSU awards. The director received a fully vested option for 2,226 shares at $242.85 and career RSUs totaling 1,278 shares (772 and 506). The 506 RSUs were issued in lieu of $123,000 in fees and career RSUs settle six months after board service ceases, which affects timing of potential share issuance. These are consistent with compensation and onboarding/redomiciliation items disclosed in the form, so the disclosure does not, by itself, indicate a material change to the company outlook.

Corporate Governance Expert

TL;DR: Insider sale plus compensation awards are disclosed; governance implications are routine but warrant monitoring.

The report shows a director-level sale and concurrent grant of equity-based awards. The option grants are noted as fully vested and the career RSUs carry post-service settlement provisions. The filing explicitly states one RSU issuance was in lieu of cash fees, and an additional legacy option tied to redomiciliation is disclosed. While insider sales can prompt investor questions, the form presents standard compensation mechanics and vesting/settlement terms rather than governance irregularities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sohi Mohsen

(Last) (First) (Middle)

70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 L2 D02 R296

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/11/2025		M		4,110	A	$64.05	26,471	D
Ordinary Shares	08/11/2025		S		4,110	D	$241.96(1)	22,361	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (right to buy)	$242.85	08/08/2025		A		2,226		(2)	08/08/2035	Ordinary Shares	2,226	$0	2,226	D
Career Restricted Stock Units	(3)	08/08/2025		A		772		(4)	(4)	Ordinary Shares	772	$0	7,244	D
Career Restricted Stock Units	(3)	08/08/2025		A		506		(4)	(4)	Ordinary Shares	506	$242.85(5)	7,750	D
Director Stock Option (right to buy)	$64.05	08/11/2025		M			4,110	(6)	08/31/2025	Ordinary Shares	4,110	$0	0	D

Explanation of Responses:

1. Price reflects a weighted average sale price for multiple transactions ranging from $241.36 to $242.295 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

2. These nonqualified stock options are fully vested and are exercisable immediately.

3. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

4. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

5. These Career Restricted Stock Units were issued to the Reporting Person in lieu of $123,000 in fees.

6. This option to purchase 4,110 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,110 ordinary shares for $64.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did STERIS (STE) report for Mohsen Sohi?

The filing shows a sale of 4,110 ordinary shares at a weighted average price of $241.96 on 08/11/2025 and equity awards on 08/08/2025 including a 2,226-share option at $242.85 and 772 and 506 career RSUs.

How many shares does the reporting person own after the transactions?

The form lists 22,361 ordinary shares beneficially owned directly following the reported transactions.

Were any awards described as fully vested or exercisable?

Yes. The filing states the 2,226-share nonqualified option is fully vested and exercisable immediately, and the career RSUs are described as fully vested.

Did any RSUs replace cash compensation?

Yes. The filing states that 506 Career Restricted Stock Units were issued to the reporting person in lieu of $123,000 in fees.

Are there any special settlement or exercise conditions disclosed?

Career Restricted Stock Units are stated to be settled in ordinary shares six months after cessation of the director's board service; an option related to redomiciliation is noted with the same original terms.

Is the option associated with redomiciliation described?

Yes. The filing discloses an option to purchase 4,110 ordinary shares at $64.05 that was received in connection with the redomiciliation and is described as fully vested.